Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 6, 2021
Quantification of KRAS inhibitor sotorasib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometryIrene A Retmana, Nancy H C Loos, Alfred H Schinkel, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 9, 2023
Validated LC-MS/MS method for simultaneous quantification of KRASG12C inhibitor sotorasib and its major circulating metabolite (M24) in mouse matrices and its application in a mouse pharmacokinetic studyIrene A Retmana, Nancy H C Loos, Alfred H Schinkel, et al.
Journal of the American Chemical Society|May 11, 2006
Photoconversion in the red fluorescent protein from the sea anemone Entacmaea quadricolor: is cis-trans isomerization involved?Davey C Loos, Satoshi Habuchi, Cristina Flors, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|July 9, 2005
[Validation of a screening test of language and learning disorders for 6-year old children (ERTLA6)--a prospective study]C Loos-Ayav, B Roy, J P Blanc, et al.
Toxicology Reports|May 22, 2023
Complications in post-mortem GHB cut-off values in urine samples: A case reportN H C Loos, K E van den Hondel, U J L Reijnders, et al.
Allergy|February 10, 2011
Drug re-challenges in cutaneous adverse drug reactions: information and effectiveness in the long-term management of patientsJ Waton, C Pouget-Jasson, C Loos-Ayav, et al.
Toxicology and Applied Pharmacology|March 25, 2024
The ABCB1 and ABCG2 efflux transporters limit brain disposition of the SYK inhibitors entospletinib and lanraplenibNancy H C Loos, Rolf W Sparidans, Paniz Heydari, et al.
Cancer Chemotherapy and Pharmacology|March 8, 2024
Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy; a preclinical assessmentNancy H C Loos, Viët Bui, Daniëlle H de Jong, et al.
Pharmacological Research|October 26, 2021
ABCB1 and ABCG2 limit brain penetration and, together with CYP3A4, total plasma exposure of abemaciclib and its active metabolitesAlejandra Martínez-Chávez, Nancy H C Loos, Maria C Lebre, et al.
Molecular Pharmaceutics|March 28, 2023
Enhancement of the Oral Availability of Cabazitaxel Using the Cytochrome P450 3A (CYP3A) Inhibitor Ritonavir in MiceNancy H C Loos, Margarida L F Martins, Daniëlle de Jong, et al.
Pageof 5